WeVote
Log In

Bill

Bill

SB 1236

Relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.

89th Legislature (2025) Introduced by César Blanco and 4 co-sponsors

SB 1236 establishes regulatory standards governing pharmacy-PBM relationships, affecting drug access, reimbursement rates, and independent pharmacy viability in Texas starting September 1, 2025.

Effective on 9/1/25
#electronicinformationsystems(i0311) #healthcareproviders(i0387) #insurance #commissionerof(v0396) #insurance--health&accident(i0422) #pharmacies&pharmacists(s1192) #pharmacybenefitmanagers(s0648)
0
WeVote Research Nonpartisan
Bill Summary · SB 1236

Legislative bill overview

SB 1236 regulates contractual relationships between pharmacists/pharmacies and health benefit plan issuers or pharmacy benefit managers (PBMs). The bill establishes standards for how these entities can interact, likely addressing issues around reimbursement rates, formulary placement, and contract terms. It became effective September 1, 2025, after being signed by the Governor in May 2025.

Why is this important

Pharmacy benefit managers significantly control drug access and costs for millions of Texans by determining which medications are covered and at what price. This legislation directly affects pharmacy profitability, drug availability, and ultimately consumer medication costs and access. The regulatory framework established here influences whether independent pharmacies can compete with large chains and whether patients face barriers to their prescribed medications.

Potential points of contention

  • PBM vs. Independent Pharmacy Balance: PBMs argue regulations increase administrative costs and reduce negotiating flexibility; pharmacies argue current practices are exploitative and reduce their viability
  • Reimbursement Rate Controls: Any mandated minimum reimbursement rates could increase insurance premiums or reduce PBM investments in pharmacy networks
  • Network Participation Requirements: Provisions on pharmacy inclusion/exclusion in networks may limit PBM flexibility while ensuring broader patient access

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.